What is Higosense?
Higosense is a pioneering health technology company specializing in mobile medical examinations. Its core offering comprises a sophisticated mobile device paired with an intuitive mobile application, all underpinned by an advanced AI-powered online health diagnostic platform. Founded in 2017 and headquartered in Warsaw, Poland, Higosense is dedicated to democratizing access to health diagnostics through accessible and intelligent technology. The company's integrated approach aims to streamline the medical examination process, providing efficient and accurate health insights.
How much funding has Higosense raised?
Higosense has raised a total of $5.6M across 1 funding round:
Series A
$5.6M
Series A (2021): $5.6M with participation from Cogito Capital Partners
Key Investors in Higosense
Cogito Capital Partners
Cogito Capital Partners is an investment firm focused on early-growth technology companies, particularly those with proven business models and strong market traction. Based in Warsaw and New York, they specialize in supporting scale-ups aiming for global expansion and market transformation.
What's next for Higosense?
With the recent major strategic investment, Higosense is poised for accelerated growth and market expansion. The capital infusion is expected to fuel further development of its AI diagnostic capabilities and enhance the reach of its mobile medical examination device. This funding round, classified as Series A, suggests Higosense is moving beyond its initial development phase and is now focused on scaling its operations, refining its technology, and capturing a larger share of the digital health market. The company's strategic focus will likely involve strengthening its technological infrastructure and expanding its service offerings to a broader user base, solidifying its position as a key player in the health tech sector.
See full Higosense company page
